Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Changmugu Medical

Request full access

Changmugu Medicalis an artificial intelligence (AI)-powered healthcare start-up

Dongcheng District, ChinaFounded 2017Health Tech & Medtech

About Changmugu Medical

Beijing Changmugu Medical Technology Co., Ltd. operates at the intersection of artificial intelligence and orthopedic surgery, providing integrated intelligent solutions for hospitals. Founded in 2018, the company has established its headquarters in Beijing, China. The founding team, which includes CEO Zhang Yiling, Chairman Liu Xingyu, and co-founder An Yicheng, possesses a blend of medical and engineering expertise from institutions like Harvard and Tsinghua University. Zhang Yiling, formerly a researcher at Harvard Medical School with over a decade of experience in orthopedic clinical practice and research, identified a critical need for better pre-operative planning tools in China to improve surgical precision.

The company targets orthopedic departments in hospitals, offering a suite of products that cover the entire surgical workflow. This includes AI-assisted diagnosis, individualized surgical planning, 3D-printed patient-specific instrumentation (PSI) surgical guides, surgical robots, and post-operative evaluation services. Its core offering, the AIJOINT® system, is an AI-powered platform for joint replacement surgery that can convert 2D CT scans into 3D models, allowing surgeons to simulate and rehearse procedures beforehand. This process aims to enhance the accuracy of implant selection and placement, potentially reducing complications like leg length discrepancy and improving patient outcomes.

Revenue is generated through the sale and service of these high-tech medical solutions. Changmugu has developed specific products like AIHIP and AIKNEE for hip and knee replacements, respectively, and the ROPA series of surgical robots. The company has secured significant funding to fuel its growth, including a Series B round of 540 million yuan ($84.3 million) in 2021. This capital is being used for new product R&D, clinical trials, production expansion, and global marketing. A key strategic partnership with Johnson & Johnson Medical China, initiated in 2019, focuses on the joint development and commercialization of digital orthopedic solutions, highlighting a collaborative business approach to penetrate the market.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
17.0/100
Industry
Health
Sub-industry
Health Platform
Sector
Core AI, Precision Medicine, Hard Tech, AI Applications, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech, Machine Learning
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2021 $84M $337M IDG Capital · CICC · CDH Investments · Yuansheng Capital —
SEEDOther financing Sep 2019 — — Legend Star · Frees Fund —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Changmugu Medical website traffic

Latest recorded traffic for Changmugu Medical is 420 monthly website visits, down 42.5% over the last three months.

Latest monthly visits420 3-month web change-42.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Changmugu Medical in the Dongcheng District ecosystem

Live from Dealroom

The Changmugu Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Legend Star
  • Frees Fund

Series A5 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Dongcheng District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Changmugu Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Changmugu Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.